Islet Sciences Inc Share Price

Stocks

Delayed OTC Markets 07:23:58 26/07/2017 pm IST			5-day change	1st Jan Change
0.0127 ^USD	+5.75%		+5.75%	-76.93%

04/15/04	Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	GL
23/15/23	Islet Sciences, Inc. Presented at 50th International Liver Conference	GL
24/15/24	Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	GL
09/15/09	Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	GL
05/15/05	Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	GL

1 day

+5.75%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ISLET SCIENCES INC	+5.75%	+5.75%	-	-	0
LONZA GROUP AG	-0.34%	+3.52%	+10.32%	+38.31%	4.89TCr
IQVIA HOLDINGS INC.	-0.73%	-0.41%	+48.84%	+36.72%	4.43TCr
REVOLUTION MEDICINES, INC.	+1.36%	+6.03%	+343.85%	+638.73%	4.38TCr
BEONE MEDICINES AG	-0.47%	-0.76%	+9.75%	+103.07%	4.15TCr
CELLTRION, INC.	+0.34%	+0.22%	+5.18%	+47.36%	3.01TCr
MEDPACE HOLDINGS, INC.	+1.00%	-1.28%	+24.23%	+156.93%	1.74TCr
EUROFINS SCIENTIFIC SE	-1.00%	-0.92%	+22.14%	+44.17%	1.5TCr
TEMPUS AI, INC.	-2.94%	+6.98%	+5.10%	-	1.49TCr
ASCENDIS PHARMA A/S	-0.86%	-4.00%	-	-	1.5TCr
Average	+0.21%	+0.61%	+58.68%	+152.19%	3.01TCr
Weighted average by Cap.	-0.19%	+1.21%	+74.75%	+168.43%